Atossa Genetics (ATOS) Launches COVID-19 HOPE Drug Development Program

Go back to Atossa Genetics (ATOS) Launches COVID-19 HOPE Drug Development Program
ATOSSA GNTCS (NASDAQ: ATOS) Delayed: 1.90 +0.07 (3.83%)
Previous Close $1.83    52 Week High $3.64 
Open $1.82    52 Week Low $0.14 
Day High $1.96    P/E N/A 
Day Low $1.78    EPS $0.00 
Volume 534,936